REPORT ID 6941

United States Pediatric Vaccines Market Report 2017

Publish Date
1-Nov-17
Pages
109
Format
Electronic (PDF)

In this report, the United States Pediatric Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Pediatric Vaccines in these regions, from 2012 to 2022 (forecast).

United States Pediatric Vaccines market competition by top manufacturers/players, with Pediatric Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Merck
    Pfizer
    Sanofi
    AstraZeneca
    Novartis
    Takeda Pharmaceutical
    Bavarian Nordic
    Baxter
    LG Life Sciences
    Lupin
    S K Chemicals
    Mitsubishi Tanabe Pharma
    Janssen
    Shenzhen Kangtai Biological Products
    Sinovac Biotech
    Bharat Biotech
    Crucell
    Dynavax
    Serum Institute of India

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Diphtheria
    Influenza
    Hepatitis
    Pneumococcal Diseases
    Meningococcal Diseases
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Newborn
    Infant
    Child
    Dolescent

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Pediatric Vaccines Market Report 2017
1 Pediatric Vaccines Overview
    1.1 Product Overview and Scope of Pediatric Vaccines
    1.2 Classification of Pediatric Vaccines by Product Category
        1.2.1 United States Pediatric Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Pediatric Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Diphtheria
        1.2.4 Influenza
        1.2.5 Hepatitis
        1.2.6 Pneumococcal Diseases
        1.2.7 Meningococcal Diseases
        1.2.8 Others
    1.3 United States Pediatric Vaccines Market by Application/End Users
        1.3.1 United States Pediatric Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Newborn
        1.3.3 Infant
        1.3.4 Child
        1.3.5 Dolescent
    1.4 United States Pediatric Vaccines Market by Region
        1.4.1 United States Pediatric Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Pediatric Vaccines Status and Prospect (2012-2022)
        1.4.3 Southwest Pediatric Vaccines Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Pediatric Vaccines Status and Prospect (2012-2022)
        1.4.5 New England Pediatric Vaccines Status and Prospect (2012-2022)
        1.4.6 The South Pediatric Vaccines Status and Prospect (2012-2022)
        1.4.7 The Midwest Pediatric Vaccines Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Pediatric Vaccines (2012-2022)
        1.5.1 United States Pediatric Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 United States Pediatric Vaccines Revenue and Growth Rate (2012-2022)

2 United States Pediatric Vaccines Market Competition by Players/Suppliers
    2.1 United States Pediatric Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Pediatric Vaccines Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Pediatric Vaccines Average Price by Players/Suppliers (2012-2017)
    2.4 United States Pediatric Vaccines Market Competitive Situation and Trends
        2.4.1 United States Pediatric Vaccines Market Concentration Rate
        2.4.2 United States Pediatric Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Pediatric Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Pediatric Vaccines Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Pediatric Vaccines Sales and Market Share by Region (2012-2017)
    3.2 United States Pediatric Vaccines Revenue and Market Share by Region (2012-2017)
    3.3 United States Pediatric Vaccines Price by Region (2012-2017)

4 United States Pediatric Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Pediatric Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Pediatric Vaccines Revenue and Market Share by Type (2012-2017)
    4.3 United States Pediatric Vaccines Price by Type (2012-2017)
    4.4 United States Pediatric Vaccines Sales Growth Rate by Type (2012-2017)

5 United States Pediatric Vaccines Sales (Volume) by Application (2012-2017)
    5.1 United States Pediatric Vaccines Sales and Market Share by Application (2012-2017)
    5.2 United States Pediatric Vaccines Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Pediatric Vaccines Players/Suppliers Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Pediatric Vaccines Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Merck
        6.2.2 Pediatric Vaccines Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Merck Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Pfizer
        6.3.2 Pediatric Vaccines Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Pfizer Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Sanofi
        6.4.2 Pediatric Vaccines Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Sanofi Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 AstraZeneca
        6.5.2 Pediatric Vaccines Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Novartis
        6.6.2 Pediatric Vaccines Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Novartis Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Takeda Pharmaceutical
        6.7.2 Pediatric Vaccines Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Bavarian Nordic
        6.8.2 Pediatric Vaccines Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Baxter
        6.9.2 Pediatric Vaccines Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Baxter Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 LG Life Sciences
        6.10.2 Pediatric Vaccines Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Lupin
    6.12 S K Chemicals
    6.13 Mitsubishi Tanabe Pharma
    6.14 Janssen
    6.15 Shenzhen Kangtai Biological Products
    6.16 Sinovac Biotech
    6.17 Bharat Biotech
    6.18 Crucell
    6.19 Dynavax
    6.20 Serum Institute of India

7 Pediatric Vaccines Manufacturing Cost Analysis
    7.1 Pediatric Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Pediatric Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Pediatric Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Pediatric Vaccines Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Pediatric Vaccines Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Pediatric Vaccines Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Pediatric Vaccines Sales Volume Forecast by Type (2017-2022)
    11.3 United States Pediatric Vaccines Sales Volume Forecast by Application (2017-2022)
    11.4 United States Pediatric Vaccines Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer